Have a personal or library account? Click to login
Fingolimod exerts in vitro anticancer activity against hepatocellular carcinoma cell lines via YAP/TAZ suppression Cover

Fingolimod exerts in vitro anticancer activity against hepatocellular carcinoma cell lines via YAP/TAZ suppression

Open Access
|Apr 2022

Authors

Jiamin Du

Zhejiang Province Key Laboratory of Anticancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China

Meijia Qian

Zhejiang Province Key Laboratory of Anticancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China

Tao Yuan

Zhejiang Province Key Laboratory of Anticancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China

Bo Zhang

Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Affiliated Hangzhou First People’s Hospital, Zhejiang University School of Medicine, Hangzhou, China

Xueqin Chen

Department of Oncology, Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Affiliated Hangzhou First People´s Hospital, Zhejiang University School of Medicine, Hangzhou, China

Ning An

Department of Pharmacy, Ningbo Medical Center Lihuili Hospital, Ningbo, China

Qiaojun He

Zhejiang Province Key Laboratory of Anticancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China

Bo Yang

Zhejiang Province Key Laboratory of Anticancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China

Song Ye

yesongivan@zju.edu.cn

Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The Second Affiliated Hospital, School of Medicine Zhejiang University, Hangzhou, China

Hong Zhu

hongzhu@zju.edu.cn

Zhejiang Province Key Laboratory of Anticancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China
Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Affiliated Hangzhou First People’s Hospital, Zhejiang University School of Medicine, Hangzhou, China
The Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, China
DOI: https://doi.org/10.2478/acph-2022-0029 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Language: English
Page range: 427 - 436
Accepted on: Jan 19, 2022
Published on: Apr 13, 2022
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:

© 2022 Jiamin Du, Meijia Qian, Tao Yuan, Bo Zhang, Xueqin Chen, Ning An, Qiaojun He, Bo Yang, Song Ye, Hong Zhu, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.